Method for detecting related substances of 5 '(E)-VPA phosphoramidite monomer
By optimizing the detection conditions using liquid chromatography, the gap in the detection of related substances of 5'(E)-VPA phosphoridamide monomer was filled, enabling quality control of small nucleic acid drugs and improving detection efficiency and accuracy.
Patent Information
- Application Number
- CN202511069596.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-07-31
- Publication Date
- 2025-11-28
AI Technical Summary
The lack of effective methods in the current technology for detecting relevant substances in 5'(E)-VPA phosphorous amide monomers increases the difficulty of purifying small nucleic acid drugs and affects drug quality control.
The detection was performed using liquid chromatography with an octadecyl-bonded silica column, ammonium acetate solution and acetonitrile as the mobile phase, gradient elution, and a UV detector. The detection conditions were optimized to avoid sample degradation, thus achieving accurate separation and detection of related substances of 5'(E)-VPA phosphorous amide monomer.
It achieves effective separation and detection of related substances of 5'(E)-VPA phosphorous amide monomer, meets pharmacopoeia standards, reduces analysis costs, can complete the detection of multiple impurities in a short time, truly reflects sample quality, and is suitable for quality control of small nucleic acid drugs.